Organon & Co. (OGN)
13.80
+0.02
(+0.18%)
USD |
NYSE |
Oct 29, 11:56
Organon EPS Diluted (Quarterly) : 0.3993 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.3993 |
| March 31, 2026 | 0.5554 |
| December 31, 2025 | -0.7879 |
| September 30, 2025 | 0.6138 |
| June 30, 2025 | 0.5574 |
| March 31, 2025 | 0.3333 |
| December 31, 2024 | 0.4194 |
| September 30, 2024 | 1.382 |
| June 30, 2024 | 0.7541 |
| March 31, 2024 | 0.778 |
| December 31, 2023 | 2.128 |
| September 30, 2023 | 0.2262 |
| June 30, 2023 | 0.9455 |
| Date | Value |
|---|---|
| March 31, 2023 | 0.6909 |
| December 31, 2022 | 0.4229 |
| September 30, 2022 | 0.89 |
| June 30, 2022 | 0.9171 |
| March 31, 2022 | 1.364 |
| December 31, 2021 | 0.7967 |
| September 30, 2021 | 1.274 |
| June 30, 2021 | 1.684 |
| March 31, 2021 | 1.574 |
| December 31, 2020 | 1.452 |
| September 30, 2020 | 2.158 |
| June 30, 2020 | 2.138 |
| March 31, 2020 | 2.773 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Viatris, Inc. | -0.1021 |
| Pacira Biosciences, Inc. | 0.1155 |
| Bristol Myers Squibb Co. | 1.620 |
| Harmony Biosciences Holdings, Inc. | 1.284 |
| ANI Pharmaceuticals, Inc. | 1.052 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 108.00M |
| Revenue (Quarterly) | 1.558B |
| Total Expenses (Quarterly) | 1.45B |
| Enterprise Value | 11.04B |
| Gross Profit Margin (Quarterly) | 54.36% |
| Profit Margin (Quarterly) | 6.93% |
| Earnings Yield | 5.65% |
| Operating Earnings Yield | 32.68% |
| Normalized Earnings Yield | 10.96 |